Table 1 Hematological and iron overload parameters of patients with β-Thalassemia Major and their subgroups based on chelation treatment in the current and previous study6
From: Renal function in β-thalassemia major patients treated with two different iron-chelation regimes
Parameter (normal range) | Current study | Previous study | ||
|---|---|---|---|---|
Iron Chelator | DFX n = 26 | DFO+/−DFP n = 10 | Total n = 36 | DFO n = 29 |
Length of current treatment (mean months) | 60.4 ± 9.1 | 101.2 ± 66.1 | ||
Hemoglobin (g/dl) (12–15) | 8.3 ± 0.95 | 8.12 ± 0.88 | 8.25 ± 0.9 | 8.9 ± 0.9 |
Serum ferritin (ng/ml) (22–322) | 2597 ± 1669** | 4801 ± 1893** | 3209 ± 1976 | 3839 ± 1780 |
Total amount of iron transfused for prior 10 years (mmol) | 1100 ± 105 | 1388 ± 80 | 1180 ± 413 | 1218 ± 391 |